RIO DE JANEIRO, BRAZIL - Brazil’s health regulator ANVISA said on Wednesday, December 2nd, it was open to approving COVID-19 vaccines for emergency use and outlined the requirements for companies looking to do so.
ANVISA said authorizations would be analyzed on a case-by-case basis and that to be considered the vaccine must be in late-stage trials in Brazil. It said no requests had been received so far.
AstraZeneca, Johnson & Johnson, Pfizer and Sinovac currently have vaccines in Phase III trials in Brazil.
The regulator said producers should still seek the usual registrations for their vaccines . . .